New drug combo shows promise against hard-to-treat bacterial infections

Researchers have developed a combination therapy pairing the antibiotic meropenem with novel inhibitors to overcome carbapenem-resistant bacteria—a growing threat in hospitals worldwide. The approach could extend the usefulness of existing antibiotics and reduce pressure to develop entirely new drugs, potentially lowering treatment costs and timelines for pharmaceutical companies.

Originaltitel: Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel fi-Lactam-Metallo- β-Lactamase Inhibitors